Polycyclic-carbamoylpyridone compounds and their pharmaceutical use

H:\rec\Intrwovn\NRPortbl\DCC\REC\2151442_ .docx-22/11/2016 Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, X, W, Yi, Y2,...

Full description

Saved in:
Bibliographic Details
Main Authors Morganelli, Philip Anthony, Lazerwith, Scott E, Chen, Xiaowu, Bacon, Elizabeth M, Pyun, Hyung-Jung, Ji, Mingzhe, Trejo Martin, Teresa Alejandra, Cai, Zhenhong R, Desai, Manoj C, Cottell, Jeromy J, Mish, Michael R, Jin, Haolun, Taylor, James G
Format Patent
LanguageEnglish
Published 08.12.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:H:\rec\Intrwovn\NRPortbl\DCC\REC\2151442_ .docx-22/11/2016 Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, X, W, Yi, Y2, Zi and Z4 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
Bibliography:Application Number: AU20160262722